Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs

被引:54
作者
Zimetbaum, P
Reynolds, MR
Ho, KKL
Gaziano, T
McDonald, MJ
McClennen, S
Berezin, R
Josephson, ME
Cohen, DJ
机构
[1] Harvard Univ, Div Cardiol, Beth Israel Deaconess Med Ctr, Clin Res Inst, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9149(03)00821-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Health care resource utilization is high for patients presenting with acute atrial fibrillation (AF). The potential for treatment algorithms to safely reduce resource consumption in this setting has not been prospectively evaluated. We designed and implemented a practice guideline for the management of patients presenting to the emergency department (ED) with the primary diagnosis of AF, with emphasis on appropriate cardioversion, use of oral rate-controlling medications, and expedited referral to an outpatient AF clinic. We prospectively collected clinical and resource utilization data on all such patients for 14 months before and after institution of the guideline. Institution of the guideline was associated with a decreased rate of hospital admission (from 74% to 38%), with no differences in ED return visits or hospital readmission within 30 days. No strokes or deaths were observed. This large decrease in resource utilization during the intervention phase of the study translated to an average decrease in 30-day total direct health care costs of approximately $1,400 per patient. Our clinical and cost outcomes were minimally affected after statistical adjustment for baseline differences between study groups. We conclude that the implementation of our practice guideline was feasible, safe, and effective. Widespread adoption of such practices may have large financial implications for the health care system. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:677 / 681
页数:5
相关论文
共 8 条
[1]   Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care [J].
Dell'Orfano, JT ;
Patel, H ;
Wolbrette, DL ;
Luck, JC ;
Naccarelli, GV .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (05) :788-790
[2]   Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation [J].
Eckman, MH ;
Falk, RH ;
Pauker, SG .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1669-1677
[3]   THE DISTINCTION BETWEEN COST AND CHARGES [J].
FINKLER, SA .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (01) :102-109
[4]   A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low-molecular-weight heparin [J].
Kim, MH ;
Morady, F ;
Conlon, B ;
Kronick, S ;
Lowell, M ;
Bruckman, D ;
Armstrong, WF ;
Eagle, KA .
ANNALS OF EMERGENCY MEDICINE, 2002, 40 (02) :187-192
[5]   PRESENTATION AND MANAGEMENT OF PATIENTS ADMITTED WITH ATRIAL-FIBRILLATION - A REVIEW OF 291 CASES IN A REGIONAL-HOSPITAL [J].
LOK, NS ;
LAU, CP .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 48 (03) :271-278
[6]  
McCaig L., 2001, NATL HOSP AMBULATORY
[7]   Acute and long-term cost implications of coronary stenting [J].
Peterson, ED ;
Cowper, PA ;
DeLong, ER ;
Zidar, JP ;
Stack, RS ;
Mark, DB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (06) :1610-1618
[8]   Incidence and predictors of myocardial infarction among patients with atrial fibrillation [J].
Zimetbaum, PJ ;
Josephson, ME ;
McDonald, MJ ;
McClennen, S ;
Korley, V ;
Ho, KFL ;
Papageorgiou, P ;
Cohen, DJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1223-1227